Second-line treatment in seronegative spondylarthropathies*
References (128)
- et al.
Psoriatic arthritis
Seminars Arthr Rheum
(1973) - et al.
Aortic insufficiency in five patients with Reiter's syndrome. A detailed clinical and pathologic study
Am J Med
(1972) - et al.
A review of methotrexate therapy in Reiter Syndrome
Semin Arthritis Rheum
(1985) - et al.
Acute aortitis and aortic incompetence due to systemich rheumatologic disorders
Int J Cardiol
(1991) - et al.
Levamisole-induced immuno-stimulation in spondylarthropathies
Lancet
(1977) Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study
Int J Immunopharmacol
(1979)- et al.
Agranulocytosis, levamisole and HLA-B27 in rheumatoid arthritis
Lancet
(1977) - et al.
Agranulocytosis, levamisole, and HLA-B27
Lancet
(1977) - et al.
Ankylosing spondylitis and HLA-B27
Lancet
(1973) Seronegative polyarthritis. A unified concept
Arthritis Rheum
(1978)
The European spondylarthropathy study group; preliminary criteria for the classification of spondylarthropathy
Arthritis Rheum
(1991)
Spondylarthropathies
(1984)
Enthesopathy of rheumatoid and ankylosing spondylitis
Ann Rheum Dis
(1971)
Prognosis in the rheumatic diseases
(1991)
Methotrexate therapy in sporiatic arthritis
JAMA
(1964)
Amethopterin (methotrexate) in connective tissue disease—psoriasis and polyarthritis
Ann Rheum Dis
(1968)
Die Ergebnisse der endoxan-therapie bei arthropathia psoriatica und rheumatoider arthritis
Med Welt
(1970)
Treatment of psoriatic arthropathy with either azathioprine or methotrexate
Rheumatol Rehab
(1974)
D-pénicillamine et polyarthrites psoriasiques
Nouv Pr Méd
(1975)
Treatment of psoriatic arthritis with 6-mercaptopurine
Arthritis Rheum
(1973)
Cyclosporin A—Wirkungen und Nebenwirkungen bei der Behandlung der chronischen Polyarthritis und der Psoriasisarthritis
Immun Infect
(1981)
Methotrexate in psoriatic arthritis: a retrospective study
Acta Dermatovener
(1983)
Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis
Arthritis Rheum
(1984)
Indices of disease activity in psoriatic arthritis
J Royal Soc Med
(1987)
Clinical response to auranofin in patients with psoriatic arthritis
Clin Rheumatol
(1989)
Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response
J Rheumatol
(1991)
A re-evaluation of the osteoarticular manifestations of psoriasis
Br J Rheumatol
(1991)
Psoriatic arthritis: an analysis of 220 patients
Q J Med
(1987)
Psoriatic: a clinical, immunological and radiological study of 180 patients
Br J Rheumatol
(1991)
Science Citation Index
(1990)
Dauerprophylaxe der rezidivierende “Spondylitischen Iridocyclitis” durch Antimalarica und nichtsteroidale Antiphlogistica
Z Rheumatol
(1982)
Penicillamine in ankylosing spondylitis: a double blind placebo controlled trial
J Rheumatol
(1985)
Clinical application of D-penicillamine in ankylosing spondylitis: a 9-month study
Rev Roum Méd Int
(1989)
D-penicillamine in the therapy of ankyosing spondylitis
Clin Rheumatol
(1989)
D-penicillamine in ankylosing spondylitis and polymyositis
Postgrad Med
(1974)
D-penicillamine in spondylitis and sacroiliitis; a preliminary study
Scand J Rheum
(1975)
Penicillamine in ankylosing spondylitis
Arthritis Rheum
(1976)
Failure of d-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA-b27-associated arthropathy
Ann Rheum Dis
(1977)
Penicillamine in seronegative polyarthritis
Ann Rheum Dis
(1977)
Ankylosing (Strümpell-Marie) spondylitis (a clinical review of 128 cases)
AIR
(1962)
Reiter's syndrome in women
Arthritis Rheum
(1980)
Zur Behandlung der Spondylitis ankylosans mit Auranofin (Ridaura)
Z Rheumatol
(1990)
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients
Br Med J
(1986)
Sulphasalazine in ankylosing spondylitis
Ann Rheum Dis
(1986)
Sulfasalazine in the treatment of ankylosing spondylitis; a twenty-six-week, placebo-controlled clinical trial
Arthritis Rheum
(1988)
Sulphsalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin
Br J Rheumatol
(1989)
A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect
Br J Rheumatol
(1990)
Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment
Clin Rheumatol
(1991)
The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years
Br J Rheumatol
(1993)
Evaluation of sulphasalazine in ankylosing spondylitis—an interventional study
Br J Rheumatol
(1990)
Cited by (0)
- *
This study was made possible by a grant from Christiaens B.V. Belgium.
- 1
From the Departments of Rheumatology and Clinical Pharmacology, University Hospital Nijmegen, St. Radboud; and the Department of Rheumatology, St. Maartens Hospital, Nijmengen, the Netherlands.
- 2
Marjonne C.W. Creemers, MD: Trainee in Rheumatology
- 3
Piet L.C.M. van Riel, MD: Associate Professor of Rheumatology
- 4
Marcel J.A.M. Franssen, MD: Rheumatologist
- 5
Levinus B.A. van de Putte, MD: Professor of Rheumatology
- 6
Frank W.J. Gribnau, MD: Professor of Clinical Pharmacology.
Copyright © 1994 Published by Elsevier Inc.